Lucy Therapeutics

Developer of proprietary mitochondrial-based small molecule therapies and diagnostic biomarkers designed for the central nervous system. The company offers genetic technologies providing unparalleled ...

Healthcare

Waltham, MA, United States

Founded 2017

12 employees

Website

Valuation

Share Price

N/A

Total Raised

$42.3M

Last Round

N/A

Investors

+11 other investors

View all 11 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Lucy Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required